Global Ganja Report

A British Columbia firm which is one of Canada's leading licensed producers of medical marijuana has entered a partnership with the national subsidiary of Sandoz, a global leader in the pharmaceutical industry. The deal is being hailed as a milestone that signals the arrival of cannabis in the corporate economy.

Several bills now pending before the Colorado state house will further shape what the legal cannabis economy will look like in the Centennial State—for better or for worse. While some of these measures would mean a freer atmosphere both for "recreational" and medicinal users, others may portend greater big-money control of the fast-growing industry.

Amid legal challenges and disputes over zoning in Detroit, Michigan's long-awaited regulatory regime for cannabis dispensaries continues to face obstacles to implementation. This has left hundreds of dispensaries operating in a "gray market"—tolerated by the authorities on an unofficial basis while the mess is being worked out. But now state authorities have started to order these outlets closed—potentially leaving thousands of registered users without access to their medicine.

Seniors are the fastest growing group of medicinal cannabis users in the coutry, and a growing number of nursing homes from coast to coast are tolerating use of tinctures and extracts to combat dementia, insomnia and related ailments. Patient testimony is now backed up by research, with scientists identifying the mechanism by which cannainoids slow the deterioration of neurons in the brain. But federal strictures continue to pose an obstacle to investigation—leaving medicinal users in the cold under US law.

Several Vietnamese immigrants who had been living legally for many years in the United States have been detained by the federal government and are facing possible deportation back to Vietnam—where they may face persecution. They've launched suit against the government over their detention and state of "legal limbo." The government says they violated terms of their status by committing crimes—including growing small quantities of cannabis.

In a sure sign of changing times, the first cannabis-industry business has been listed on the NASDAQ stock exchange—raising clear questions about how long prohibition can hang on in the face of a burgeoning economic sector. Toronto-based medical marijuana producer Cronos Group won approval from the US Securities and Exchange Commission (SEC) to become the first cannabis company listed on NASDAQ, New York City's second biggest stock market, Bloomberg reported Feb. 26.

Despite repeated pledges by the New York Police Department and Mayor Bill de Blasio to lift the police pressure on cannabis, and especially to address the long-standing racial disparity in pot busts, all too little seems to be changing in Gotham. In a sometimes heated session, New York's City Council held hearings Feb. 26 to discuss new stats showing that despite a significant drop in cannabis arrests, the overwhelming majority of those busted remain Black and Latino.

A judge for the US District Court for the Southern District of New York on Feb. 26 dismissed a lawsuit challenging the Schedule I classification for cannabis under the Controlled Substances Act. Judge Alvin Hellerstein granted the government's motion to dismiss because the plaintiffs failed to exhaust all administrative remedies prior to initiating the suit. The "exhaustion rule" requires "that parties exhaust prescribed administrative remedies before seeking relief from federal courts."